Archive
CDMO Samsung Biologics’ $897 Million Pfizer Partnership Signals the Po...
Samsung Biologics, a contract development and manufacturing organization (CDMO), recently added to its industry-leading biomanufacturing capacity with the completion of its fourth plant. Plant 4, which became fully
